Medicine & Health

Sarah Moreland-Russell, at the Brown School at Washington University in St. Louis, has received a four-year $2.65 million grant from the National Institutes of Health (NIH) to understand how schools respond to changes in policy guiding school lunch and breakfast programs affect health.

An analysis by researchers at WashU Medicine interprets the benefits of new Alzheimer’s drugs in a way that aims to help patients and families make informed treatment decisions.

Heath Rutledge-Jukes, 25, a second-year student at WashU Medicine, has earned a spot on Forbes’ “30 Under 30” education list.

WashU has celebrated Sandro Galea’s installation as dean, marking a major milestone for public health and the launch of its first new school in a century.

Neuroscientist Juliet Mwirigi, a postdoctoral researcher in the Department of Anesthesiology at WashU Medicine, has been named a Hanna H. Gray Fellow by the Howard Hughes Medical Institute.

A Washington man who inherited a mutation that should have caused him to develop Alzheimer’s decades ago remains mentally sharp. A new study of his case by researchers at WashU Medicine aims to identify potential routes to preventing or treating the disease.

WashU Olin Business School recently launched a new health initiative that envisions Olin as the premier institution for the business of health and an engine for innovation at WashU. 

WashU Medicine and the Weizmann Institute of Science have launched a collaboration to support joint research projects focused on understanding the role of microbes and the immune and nervous systems in human health and disease.

A nasal vaccine for COVID-19 – based on technology developed at Washington University in St. Louis – is poised to enter a phase 1 clinical trial in the U.S.

The first participants have been enrolled in an international clinical trial, led by WashU Medicine, aimed at preventing Alzheimer’s disease in young adults at high risk of the disease.